Cubist Systematic Strategies, LLC Xenon Pharmaceuticals Inc. Transaction History

Cubist Systematic Strategies, LLC

$15.8 Billion
Q3 2024

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$42.66 - $50.04 $217,779 - $255,454	5,105 New	5,105 $219,000
Q1 2023 May 15, 2023	BUY	$33.46 - $40.35 $59,491 - $71,742	1,778 Added 1004.52%	1,955 $69,000
Q4 2022 Feb 14, 2023	SELL	$33.06 - $39.43 $662,324 - $789,940	-20,034 Reduced 99.12%	177 $6,000
Q3 2022 Nov 14, 2022	SELL	$30.79 - $39.82 $999,658 - $1.29 Million	-32,467 Reduced 61.63%	20,211 $730,000
Q2 2022 Aug 15, 2022	SELL	$25.44 - $35.16 $543,423 - $751,052	-21,361 Reduced 28.85%	52,678 $1.6 Million
Q1 2022 May 16, 2022	BUY	$25.09 - $33.13 $1.49 Million - $1.97 Million	59,498 Added 409.17%	74,039 $2.26 Million
Q4 2021 Feb 14, 2022	BUY	$15.6 - $35.4 $103,786 - $235,516	6,653 Added 84.34%	14,541 $454,000
Q3 2021 Nov 15, 2021	BUY	$14.86 - $19.45 $89,858 - $117,614	6,047 Added 328.46%	7,888 $121,000
Q2 2021 Aug 16, 2021	SELL	$16.81 - $20.0 $63,373 - $75,400	-3,770 Reduced 67.19%	1,841 $34,000
Q1 2021 May 17, 2021	SELL	$13.65 - $21.31 $5,214 - $8,140	-382 Reduced 6.37%	5,611 $100,000
Q4 2020 Feb 16, 2021	BUY	$9.49 - $16.04 $1,641 - $2,774	173 Added 2.97%	5,993 $92,000
Q3 2020 Nov 16, 2020	SELL	$10.82 - $13.35 $103,763 - $128,026	-9,590 Reduced 62.23%	5,820 $64,000
Q2 2020 Aug 14, 2020	SELL	$10.21 - $14.9 $9,158 - $13,365	-897 Reduced 5.5%	15,410 $193,000
Q1 2020 May 15, 2020	SELL	$8.08 - $17.57 $74,400 - $161,784	-9,208 Reduced 36.09%	16,307 $185,000
Q4 2019 Feb 14, 2020	BUY	$8.11 - $14.65 $193,593 - $349,710	23,871 Added 1452.01%	25,515 $335,000
Q3 2019 Nov 14, 2019	SELL	$8.74 - $10.51 $24,699 - $29,701	-2,826 Reduced 63.22%	1,644 $15,000
Q2 2019 Aug 14, 2019	SELL	$8.51 - $10.75 $22,891 - $28,917	-2,690 Reduced 37.57%	4,470 $44,000
Q1 2019 May 15, 2019	BUY	$6.39 - $10.42 $4,313 - $7,033	675 Added 10.41%	7,160 $73,000
Q4 2018 Feb 14, 2019	BUY	$5.61 - $12.62 $36,380 - $81,840	6,485 New	6,485 $41,000
Q3 2018 Nov 14, 2018	SELL	$9.0 - $14.9 $5,400 - $8,940	-600 Closed	0 $0
Q2 2018 Aug 14, 2018	SELL	$4.8 - $9.2 $7,680 - $14,719	-1,600 Reduced 72.73%	600 $6,000
Q1 2018 May 15, 2018	BUY	$2.7 - $4.9 $5,670 - $10,290	2,100 Added 2100.0%	2,200 $11,000
Q4 2017 Feb 14, 2018	BUY	$2.2 - $3.25 $220 - $325	100	100 $0

Others Institutions Holding XENE

# of Institutions

212

Shares Held

70.2M

Call Options Held

88.3K

Put Options Held

28.8K

Avoro Capital Advisors LLC New York, NY

5.67M
Shares

$220 Million
3.36% of portfolio
Driehaus Capital Management LLC Chicago, IL

4.6M
Shares

$179 Million
1.77% of portfolio
Wellington Management Group LLP Boston, MA

3.84M
Shares

$150 Million
0.03% of portfolio
Braidwell LP Stamford, CT

2.71M
Shares

$105 Million
3.02% of portfolio
Commodore Capital LP New York, NY

2.7M
Shares

$105 Million
9.03% of portfolio

View Full List

About Xenon Pharmaceuticals Inc.

Ticker XENE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,263,500
Market Cap $2.42B
Description
Xenon Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics to treat patients with neurological disorders in Canada. Its clinical development pipeline includes XEN496, A Kv7 potassium channel opener that is Phase III clinical trials for the treatment of KCNQ2 developmental and epilepsy encephalopath...

More about XENE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.

Account